NCT02863926 - Use of Autologous Concentrated Bone Marrow Aspirate in Preventing Wound Complications in Below Knee Amputation (BKA) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 6, 2017

Primary Completion Date

July 27, 2018

Study Completion Date

July 27, 2018

Conditions

Peripheral Artery DiseaseVascular DiseaseCritical Limb Ischemia

Interventions

BIOLOGICAL

Injection of cBMA aspirate into the index leg

Injection of cBMA into the anterior tibialis muscle and upper index leg of subjects scheduled for semi-elective BKA 7-21 days before surgery

Trial Locations (1)

Indiana University School of Medicine, Indianapolis